MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-22-2026
Country |
 USA |
IPO year |
2000 |
Industry |
Medical instruments |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
357 M |
Market Cap[1] |
$ 172 B |
EBITDA (LTM) |
$ 2.95 B |
P/E (LTM) |
59.68 |
P/S (LTM) |
17.26 |
EPS (LTM) |
8.08 |
Intuitive Surgical is an American company that designs and manufactures surgical robots and related software. The company was founded in 1995 and is headquartered in Santa Clara, California.
Intuitive Surgical is a leader in the field of surgical robotics and provides its products in more than 60 countries around the world. Its main product, the Da Vinci system, allows surgeons to perform complex surgeries with high precision and minimal impact on the patient's body.
The company actively invests in research and development of new technologies to improve its products and expand its range. It also provides training and support for surgeons using its systems.
Intuitive Surgical adheres to high standards of quality and safety, and strives to improve the accessibility of its products to more patients around the world. The company continues to grow and develop to remain a leader in the field of surgical robotics and help people worldwide.
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | USA |
 |
Alcon
ALC
|
$ 75.8 | -0.08 % | $ 40.4 B | NYSE |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
$ 10.99 | 1.48 % | $ 26.7 M | Nasdaq Capital Market | USA |
 |
The Cooper Companies
COO
|
$ 64.42 | -0.82 % | $ 12.8 B | NYSE,SPB | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | USA |
 |
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | USA |
 |
iRhythm Technologies
IRTC
|
$ 122.35 | 0.73 % | $ 3.92 B | Nasdaq Global Select Market,SPB | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | USA |
 |
Repro Med Systems
KRMD
|
$ 3.96 | -0.75 % | $ 183 M | Nasdaq Capital Market | USA |
 |
Haemonetics Corporation
HAE
|
$ 59.93 | 0.52 % | $ 3.02 B | NYSE,SPB | USA |
 |
electroCore
ECOR
|
$ 6.18 | -0.08 % | $ 52.4 K | Nasdaq Global Select Market | USA |
 |
ICU Medical
ICUI
|
$ 124.82 | 0.22 % | $ 3.08 B | Nasdaq Global Select Market,SPB | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.8 | -0.89 % | $ 4.5 B | NYSE | USA |
 |
Microbot Medical
MBOT
|
$ 2.2 | 0.92 % | $ 101 M | Nasdaq Global Select Market |  Israel |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | USA |
 |
Glaukos Corporation
GKOS
|
$ 121.48 | 0.5 % | $ 5.88 B | NYSE,SPB | USA |
 |
Masimo Corporation
MASI
|
$ 178.63 | -0.04 % | $ 9.52 B | Nasdaq Global Select Market,SPB | USA |
 |
Milestone Scientific
MLSS
|
$ 0.32 | -1.27 % | $ 26.3 M | NYSE American | USA |
 |
InfuSystem Holdings
INFU
|
$ 10.34 | 0.68 % | $ 214 M | NYSE American | USA |
 |
Merit Medical Systems
MMSI
|
$ 68.58 | -0.04 % | $ 4.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Pulse Biosciences
PLSE
|
$ 23.02 | -5.07 % | $ 1.55 B | Nasdaq Global Select Market | USA |
 |
Retractable Technologies
RVP
|
$ 0.65 | 0.2 % | $ 19.5 M | NYSE American | USA |
 |
Pro-Dex
PDEX
|
$ 52.1 | 2.24 % | $ 171 M | Nasdaq Global Select Market | USA |
 |
LeMaitre Vascular
LMAT
|
$ 113.45 | 0.49 % | $ 2.57 B | Nasdaq Global Market,SPB | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | USA |
 |
STAAR Surgical Company
STAA
|
$ 25.67 | 3.34 % | $ 1.27 B | Nasdaq Global Market,SPB | USA |
 |
STERIS plc
STE
|
$ 221.8 | -0.77 % | $ 21.9 B | NYSE,SPB | USA |
 |
BioLife Solutions
BLFS
|
$ 21.38 | -1.57 % | $ 985 M | Nasdaq Global Select Market | USA |
 |
Stereotaxis
STXS
|
$ 1.93 | -1.53 % | $ 176 M | NYSE American | USA |
 |
Baxter International
BAX
|
$ 18.16 | -1.39 % | $ 9.32 B | NYSE,SPB | USA |
 |
ResMed
RMD
|
$ 219.85 | 0.15 % | $ 32.1 B | NYSE,SPB | USA |
 |
Teleflex Incorporated
TFX
|
$ 136.56 | -0.07 % | $ 6.09 B | NYSE,SPB | USA |
 |
AtriCure
ATRC
|
$ 29.28 | 3.79 % | $ 1.4 B | Nasdaq Global Market,SPB | USA |
 |
Harvard Bioscience
HBIO
|
$ 6.86 | 1.18 % | $ 305 M | Nasdaq Global Market | USA |
 |
Utah Medical Products
UTMD
|
$ 67.17 | -1.03 % | $ 218 M | Nasdaq Global Select Market | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | USA |
 |
West Pharmaceutical Services
WST
|
$ 306.16 | -1.14 % | $ 22.1 B | NYSE,SPB | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.91 | 0.08 % | $ 2.37 B | Nasdaq Global Select Market,SPB | USA |
 |
AngioDynamics
ANGO
|
$ 11.1 | -0.89 % | $ 453 M | Nasdaq Global Select Market | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 152.14 | -1.74 % | $ 43.8 B | NYSE,SPB | USA |
 |
Nephros
NEPH
|
$ 2.87 | 1.06 % | $ 29.8 M | Nasdaq Global Select Market | USA |
 |
OraSure Technologies
OSUR
|
$ 3.0 | -1.64 % | $ 220 M | Nasdaq Global Select Market,SPB | USA |
 |
Repligen Corporation
RGEN
|
$ 117.6 | 3.1 % | $ 6.55 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.